scispace - formally typeset
S

Simon C. Watkins

Researcher at University of Pittsburgh

Publications -  999
Citations -  75771

Simon C. Watkins is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Apoptosis & Immune system. The author has an hindex of 135, co-authored 950 publications receiving 68358 citations. Previous affiliations of Simon C. Watkins include Harvard University & Children's National Medical Center.

Papers
More filters
Journal ArticleDOI

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

TL;DR: The data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met and suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T-cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.
Journal ArticleDOI

Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium.

TL;DR: It is concluded that basal cells represent an alternative multipotent progenitor cell population of bronchial airways and that progenitors cell selection is dictated by the type of airway injury.
Journal ArticleDOI

Skeletal Muscle Lipid Content and Oxidative Enzyme Activity in Relation to Muscle Fiber Type in Type 2 Diabetes and Obesity

TL;DR: Based on single-fiber analysis, skeletal muscle in obese and type 2 diabetic subjects mani-fests disturbances of oxidative enzyme activity and increased lipid content that are independent of the effect of fiber type are found.
Journal ArticleDOI

Intramuscular lipid content is increased in obesity and decreased by weight loss

TL;DR: Lipid accumulation within muscle fibers is significantly increased in obesity and is reduced by weight loss, which provides important information regarding the accumulation and distribution of skeletal muscle triglyceride in type 2 DM and obesity.